FDA cleared for bladder samples hybridized with Abbott’s UroVysion™ FISH probe

BioView’s automated application for the imaging and analysis of cells in voided urine samples facilitates and eases case review and reporting processes.

The ability to efficiently scan, classify and analyze cells hybridized with Abbott’s UroVysionTM Bladder Cancer Kit, enables fast and accurate detection of aneuploidy for chromosomes 3, 7, 17 and loss of the 9p21 locus.

The application is not available in all markets.

For additional information visit our Regulatory Approvals Page